• Explore /
  • Poster
  • / A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas.

A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas.

Abstract Poster

Authors

null

Mrinal M. Gounder

Memorial Sloan Kettering Cancer Center, New York, NY

Mrinal M. Gounder , Herbert H. F. Loong , Kjirsten Nyquist-Schultz , Stephanie Baker , Yelena Ustoyev , Lanier R. Tanner , Sharon Shacham , Dilara McCauley , Tami Rashal , Jean-Richard Saint-Martin , Eran Shacham , Sharon Friedlander , Sharon Tamir , Tracey Marshall , Yosef Landesman , Michael Kauffman , Sasha Rebello , Mansoor Raza Mirza , Gary K. Schwartz , Albiruni R. A. Razak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT01896505

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 10587)

DOI

10.1200/jco.2014.32.15_suppl.10587

Abstract #

10587

Poster Bd #

294

Abstract Disclosures

Similar Posters

First Author: Mrinal M. Gounder

First Author: Ulrik Niels Lassen

First Author: John Martignetti

First Author: Morten Mau-Soerensen